Skip to main content
Top
Published in:

01-03-2018 | Case report

Rituximab

Tachycardia as an infusion-related reaction: case report

Published in: Reactions Weekly | Issue 1/2018

Login to get access

Excerpt

In a study of 142 patients, a patient [age and sex not stated] was described, who developed tachycardia as an infusion-related reaction during treatment with rituximab [Truxima; dosage and indication not stated; time to reaction onset not clearly stated]. …
Literature
go back to reference Shah R, et al. Evaluation of the safety and tolerability of rapid infusion of biosimilar rituximab Truxima - The University College London Hospitals (UCLH) experience. Blood 130 (Suppl. 1): 3387, Dec 2017 [abstract] - UnitedKingdom Shah R, et al. Evaluation of the safety and tolerability of rapid infusion of biosimilar rituximab Truxima - The University College London Hospitals (UCLH) experience. Blood 130 (Suppl. 1): 3387, Dec 2017 [abstract] - UnitedKingdom
Metadata
Title
Rituximab
Tachycardia as an infusion-related reaction: case report
Publication date
01-03-2018
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2018
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-018-44152-x